PRA International

PRA’s Late Phase Services group supports global and regional Post-Approval studies. Our highly-experienced team assists sponsors with the Post-Marketing process by planning and conducting Post-Authorisation Safety Studies/Safety-Surveillance Studies, Drug Utilisation Studies, Large Simple Trials (LSTs), Registries, Restricted Access Programs and Risk Management Programs. With many years experience managing late phase studies ranging in size from 60 to 18,000 patients in over 40 countries, our international management team leads a truly global late phase team with centralized locations in Horsham, PA, USA and Mannheim, Germany. PRA supports our Late Phase Services operational team with industry-leading strategic, scientific, medical, and epidemiological experts.

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We specialize in oncology, CNS, respiratory/allergy, cardiovascular and infectious diseases. PRA has supported over 2,100 clinical trials in more than 65 countries on 6 continents through our global offices.